Brief: Exagen Posts Q3 Loss Per Share Of $0.42
Nov 10 (Reuters) - Exagen Inc XGN.O :
* . REPORTS THIRD QUARTER 2021 RESULTS
* SEES FY REVENUE $47 MILLION TO $49 MILLION
* Q3 REVENUE ROSE 14 PERCENT TO $12.3 MILLION
* QTRLY LOSS PER SHARE $0.42
Source text for Eikon: ID:nGNX8slcRT
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance